Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Archives of Cardiovascular Diseases
|
April 21, 2009
Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents
Axel De Labriolle, Laurent Bonello, Gilles Lemesle, et al.
The American Journal of Cardiology
|
April 26, 2008
Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus
Ashesh N Buch, Aamir Javaid, Daniel H Steinberg, et al.
The American Journal of Cardiology
|
May 21, 2008
Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels
Probal Roy, Vikram Raya, Teruo Okabe, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 16, 2007
Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets
Probal Roy, Rebecca Torguson, Teruo Okabe, et al.
The American Journal of Cardiology
|
September 11, 2007
Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents
Probal Roy, Teruo Okabe, Tina L Pinto Slottow, et al.
The American Journal of Cardiology
|
July 22, 2008
Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock
Laurent Bonello, Axel De Labriolle, Probal Roy, et al.
American Heart Journal
|
April 21, 2009
Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions
Laurent Bonello, Axel De Labriolle, Gilles Lemesle, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
July 15, 2009
Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty
Laurent Bonello, Axel de Labriolle, Probal Roy, et al.
Heart, Lung & Circulation
|
August 15, 2021
In Hospital Outcomes for High-Risk Percutaneous Coronary Intervention (PCI) in Patients Referred From a Rural Centre to Metropolitan Sites
Rajan Rehan, Elise Kempler, Kath McMaster, et al.
International Journal of Cardiology
|
February 10, 2009
Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents
Laurent Bonello, Ashesh N Buch, Axel De Labriolle, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Archives of Cardiovascular Diseases
|
April 21, 2009
Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents
Axel De Labriolle, Laurent Bonello, Gilles Lemesle, et al.
The American Journal of Cardiology
|
April 26, 2008
Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus
Ashesh N Buch, Aamir Javaid, Daniel H Steinberg, et al.
The American Journal of Cardiology
|
May 21, 2008
Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels
Probal Roy, Vikram Raya, Teruo Okabe, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 16, 2007
Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets
Probal Roy, Rebecca Torguson, Teruo Okabe, et al.
The American Journal of Cardiology
|
September 11, 2007
Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents
Probal Roy, Teruo Okabe, Tina L Pinto Slottow, et al.
The American Journal of Cardiology
|
July 22, 2008
Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock
Laurent Bonello, Axel De Labriolle, Probal Roy, et al.
American Heart Journal
|
April 21, 2009
Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions
Laurent Bonello, Axel De Labriolle, Gilles Lemesle, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
July 15, 2009
Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty
Laurent Bonello, Axel de Labriolle, Probal Roy, et al.
Heart, Lung & Circulation
|
August 15, 2021
In Hospital Outcomes for High-Risk Percutaneous Coronary Intervention (PCI) in Patients Referred From a Rural Centre to Metropolitan Sites
Rajan Rehan, Elise Kempler, Kath McMaster, et al.
International Journal of Cardiology
|
February 10, 2009
Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents
Laurent Bonello, Ashesh N Buch, Axel De Labriolle, et al.
Page
of 6